The device uses controlled freezing to adhere to and remove targeted tissue or foreign material, enabling clinicians to perform both diagnostic and therapeutic interventions through a bronchoscope.
The company has registered the software as a Software as a Medical Device (SaMD) and says it provides clinical-grade hearing assessment results.
Under the revised agreement, Exor can raise its shareholding in Philips to up to 22% of the company’s issued ordinary share capital and voting rights, compared with the previous 20% limit.
The procedures represent the first clinical use of the Aliya EX System since it received U.S. Food and Drug Administration (FDA) 510(k) clearance in May 2026.
The AI-powered guidance will focus on building sustainable habits related to diet, physical activity, recovery and sleep, helping individuals make informed lifestyle decisions in real time.
The approval allows the company’s PGDx elio tissue complete CDx to be used in hospitals and clinical laboratories across the United States to help identify patients who may benefit from targeted treatment.
The partnerships will enable healthcare providers to integrate wearable and out-of-hospital monitoring technologies into the Philips ecosystem.
SMT’s adoption of Teamcenter is intended to improve visibility into product development activities while helping the company manage the documentation and controls required in the highly regulated medical device industry.
The company has launched Invenia Automated Breast Ultrasound (ABUS) Prime and ABUS StreamVue, which target different stages of the breast imaging workflow.
Under the definitive agreement, KKR will acquire all outstanding shares of Integer Holdings for US$127 per share in cash.